Zoladex_versus_orchiectomy_in_treatment_of_advanced_prostate_cancer:_a_randomized_trial._Zoladex_Prostate_Study_Group._We_report_preliminary_results_for_the_first_164_patients_enrolled_in_a_multicenter_study_comparing_the_endocrine_effects,_efficacy,_and_safety_of_3.6_mg_of_goserelin_acetate_(Zoladex)_and_orchiectomy_in_patients_with_Stage_D2_prostate_cancer._Eighty-one_patients_were_randomly_allocated_to_receive_Zoladex_and_83_to_orchiectomy._The_median_follow-up_time_for_all_patients_was_two_hundred_ten_days._Median_serum_levels_of_testosterone_were_reduced_to_castrate_levels_(less_than_50_ng/dL)_within_four_weeks_in_both_groups_and_remained_suppressed_for_up_to_sixty_weeks._An_objective_response_according_to_modified_criteria_of_the_National_Prostatic_Cancer_Project_was_observed_in_81_percent_and_78_percent_of_patients_in_the_Zoladex_and_orchiectomy_groups,_respectively._There_were_no_statistically_significant_differences_between_treatment_groups_in_the_distributions_of_time_to_treatment_failure_or_time_to_disease_progression._The_most_commonly_reported_adverse_events_in_both_treatment_groups_were_hot_flashes,_cancer-related_pain,_unspecified_pain,_and_urinary_symptoms._These_results_suggest_that_Zoladex_may_offer_an_alternative_to_orchiectomy_in_the_treatment_of_advanced_prostate_cancer.